Seminars

Below you can find a list of all upcoming seminars at our research center. These include both internal and external speakers. An overview of other events, including outreach and social activities, can be found here.

All upcoming seminars

  • Fri
    19
    Oct
    2018

    Rob Meijers

    12:00 pmAuditorium ON4

    EMBL Hamburg, Germany

    'Structures of human DSCAM may reveal it is an adhesion sensor'

     

  • Tue
    23
    Oct
    2018

    Dirk Vandekerkhove & Rodrigo Gallardo

    1:00 pmAuditorium ON4

    ‘Title TBC’
    by Dirk Vandekerkhove, Verstreken lab

    'Title TBC'
    by Rodrigo Gallardo, Protein biophysics Expertise Unit

    Cancer & Neuro Program Progress Seminar Series

  • Mon
    29
    Oct
    2018

    Natalia Rodriguez Muela

    10:00 amAuditorium ON4

    Biological Research Center, Madrid & Harvard University, Boston

    'Resistance versus vulnerability: unraveling the fate of neuronal subtypes in neuropathologies'

  • Tue
    06
    Nov
    2018

    Cedric Thues & Laura Vangeel

    1:00 pmAuditorium ON4

    ‘Title TBC’
    by Cedric Thues, Verstreken lab

    'Title TBC'
    by Laura Vangeel, Voets lab

    Cancer & Neuro Program Progress Seminar Series

  • Thu
    15
    Nov
    2018

    Sheena Radford

    4:00 pmAuditorium O&N4

    University of Leeds, UK

    Title TBC

    VIB & KU Leuven Distinguished Lecture Series

Previous speakers

  • Matthijs Verhage, VUmc Amsterdam, the Netherlands
  • Benoit Vanhollebeke, ULB, Belgium
  • Rosa Rademakers, Mayo Clinic, USA
  • Christian Klämbt, University of Münster, Germany
  • Tara Spires-Jones, University of Edinburgh, UK
  • Ryan Watts, Denali Therapeutics, USA
  • Siddhartan Chandran, University of Edinburgh, UK
  • Stephen Lawrence Zipursky, UCLA & HHMI, USA
  • Arnold Kriegstein, UCSF, USA
  • Phyllis Hanson, WU St. Louis, USA
  • Carlos Dotti, CSIC, Spain
  • Detlev Arendt, EMBL, Germany
  • Frank Bradke, DZNE, Germany
  • Roosmarijn Vandenbroucke, UGent, Belgium
  • Aya Takeoka, NERF, Belgium
  • Jose Tomas Bras & Rita Louro Guerreiro, UCL, UK
  • Zsuzsanna Callaerts-Vegh, KU Leuven, Belgium
  • Jeff Lichtman, Harvard University, USA
  • Silvio Rizzoli, University Medical Center Göttingen, Germany
  • Cédric Blanpain, ULB, Belgium
  • Frederic A. Meunier, Queensland Brain Institute, Australia
  • Kirill Martemyanov, Scripps Research Institute, Florida, USA
  • Anthony Mathelier, University of Oslo, Norway
  • Jonathan Kipnis, University of Virginia, USA
  • Erik M. Jorgensen, Howard Hughes Medical Institute, University of Utah, Salt Lake City, USA
  • Pierre Vanderhaeghen, Institute of Interdisciplinary Research, ULB, Belgium
  • Mario Pende, INSERM, Paris, France
  • Nils Brose, Max Planck Institute of Experimental Medicine, Göttingen, Germany
  • Lukas Sommer, University of Zurich, Switzerland
  • Robert Baloh, Cedars-Sinai Regeneration Medicine Institute, LA, USA
  • Mark Kearney, University of Leeds, UK
  • Thomas Biederer, Tufts University School of Medicine, Boston, USA
  • Edward Pearce, Max Planck Institute of Immunobiology and Epigenetics, University of Freiburg, Germany
  • Tom Luedde, University Hospital RWTH Aachen, Germany
  • Juan Larrain, P. Universidad Católica de Chile
  • Jeroen Pasterkamp, Brain Center Rudolf Magnus, University Medical Center Utrecht, The Netherlands
  • David H Rowitch, University of Cambridge, UK
  • Simon Hippenmeyer, Institute of science and technology (IST), Austria
  • Nick C Fox, UCL, UK
  • Natalie Ryan, UCL, UK
  • Bogdan Munteanu, Mannheim University, Germany